Skip to content
Delayed ~15 min

KROS KEROS THERAPEUTICS

Health Care · Russell 2000

Next earnings: not announced yet

What 11 analyst firms say about KEROS THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

9.36 USD−0.09 (−0.95%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+115.0%to the avg target 20.13 USD+10.77 USD
Buy 5 · Hold 5 · Sell 0

10 rated views · 11 analyst/firm records · 11 firms

Latest report27 Aug 2026avg report date 25 May
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8046
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8026

Recent analyst activity · last 90 days

Our tracked history has 2 reports on KROS from 2 analyst firms in the last 90 days (11 firms in the past year).

Comparing each firm's latest target with its previous one: 1 has its first observed target in the past year.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesJason ZemanskyHold28 Nov 202519.00 USD
H.C. WainwrightAndres Y MaldonadoBuy15 May 202620.00 USD
Leerink PartnersThomas J SmithBuy4 Aug 202623.00 USD
OppenheimerAndreas ArgyridesBuy12 Nov 202527.00 USD
TD CowenUnnamed analystHold19 Dec 2025—
TruistSrikripa DevarakondaBuy7 Aug 202625.00 USD
WedbushYun ZhongHold4 Aug 202616.00 USD
Weiss RatingsUnnamed analyst—12 Aug 2026—
Wells FargoBenjamin BurnettBuy4 Aug 202618.00 USD
William BlairMatt PhippsHold4 Aug 2026—
Data feed RESEARCHResearch TeamHold27 Aug 202613.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 06:59 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.